References
- Boushey C J, Beresford S A, Omenn G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995; 274: 997–1092
- Ueland P M, Refsum H, Brattstrøm L. Plasma homocysteine and cardiovascular disease. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function, R B Francis, Jr. Marcel Dekker, New York 1992; 183–236
- Finkelstein J D. Methionine metabolism in mammals. J Nutr Biochem 1990; 1: 228–37
- Ueland P M, Refsum H, Stabler S P, Malinov M R, Andersson A, Allen R H. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764–79
- Tomkin G H, Hadden D R, Weaver J A, Montgomery D AD. Vitamin-B12status of patients on long-term metformin therapy. Br Med J 1971; 2: 685–7
- Carpentier J-L, Luyckx B A, Lefebvre P. Vitamin B12 and folic acid serum levels in diabetics under various therapeutic regimens. Diabet Metab 1976; 2: 187–90
- Berchtold P, Dahlqvist A, Gustafson A, Asp N-G. Effects of a biguanide (metformin) on vitamin B12 and folic acid absorption and intestinal enzyme activities. Scand J Gastroenterol 1971; 6: 751–4
- DeFronzo R A, Goodman A M. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541–9
- Carlsen S M, Rossvoll O, Bjerve K S, Følling I. Metformin improves the blood lipid pattern in nondiabetic patients with coronary heart disease. J Int Med 1996; 239: 227–33
- Fiskerstrand T, Refsum H, Kvalheim G, Ueland P M. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263–71
- Refsum H, Ueland P M, Svardal A M. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989; 35: 1921–7
- Nygård O, Vollset S E, Refsum H, Stensvold I, Tverdal A, Nordrehaug J E, et al. Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. J Am Med Assoc 1995; 274: 1526–33
- Schneede J, Ueland P M. Application of capillary electrophoresis with laser-induced fluorescence detection for routine analysis of methylmalonic acid in human serum. Analyt Chem 1995; 67: 812–19
- Adams J F, Clark J S, Ireland J T, Kesson C M, Watson W S. Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia 1983; 24: 16–18
- Caspary W F, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides. Diabetologia 1977; 13: 187–93
- Carmel R. Subtle and atypical cobalamin deficiency states. Am J Hematol 1990; 34: 108–14
- Allen R H, Stabler S P, Savage D G, Lindenbaum J. Diagnosis of cobalamin deficiency. 1. Usefulness of serum methyl malonic acid and total homocysteine concentration. Am J Hematol 1990; 34: 90–8
- Pennypacker L C, Allen R H, Kelly J P, Matthews L M, Grigsby J, Kaye K, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Amer Ger Soc 1992; 40: 1197–1204
- Savage D G, Lindenbaum J, Stabler S P, Allan R H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96: 239–46
- Bergman U, Boman G, Wiholm B-E. Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J 1978; 2: 464–6
- Arnesen E, Refsum H, Bønaa K H, Ueland P M, Førde P M, Nordrehaug J E. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704–9
- Perry I J, Refsum H, Morris R W, Ebrahim S B, Ueland P M, Shaper A G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395–8
- Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993; 103(2)149–57